Iterum Therapeutics PLC


Download Data

Iterum Therapeutics PLC Market Capitalization on May 17, 2024: USD 23.34 M

Iterum Therapeutics PLC Market Capitalization is USD 23.34 M on May 17, 2024, a 59.32% change year over year. Market capitalization is a financial metric that represents the total value of a publicly traded company. It is calculated by multiplying the current share price of a company by the total number of outstanding shares. Market capitalization is used to assess the size and relative value of a company in the stock market. It provides investors with an idea of the company's overall worth and is often used as a basis for comparing companies within the same industry or sector. A higher market capitalization generally indicates a larger, more established company.
  • Iterum Therapeutics PLC 52-week high Market Capitalization is USD 30.86 M on November 24, 2023, which is 32.22% above the current Market Capitalization.
  • Iterum Therapeutics PLC 52-week low Market Capitalization is USD 8.72 M on October 25, 2023, which is -62.63% below the current Market Capitalization.
  • Iterum Therapeutics PLC average Market Capitalization for the last 52 weeks is USD 17.83 M.

Iterum Therapeutics PLC

CEO Mr. Corey N. Fishman
IPO Date May 25, 2018
Location Ireland
Headquarters Fitzwilliam Court, Dublin, Ireland, 2
Employees 14
Sector Healthcare
Industry Biotechnology

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.

Similar companies


Hoth Therapeutics Inc

USD 1.18


StockViz Staff

May 20, 2024

Any question? Send us an email